Sintx Technologies, Inc.

SINT ·Healthcare, Medical Devices, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $4.1M $3.6M $3.3M $6.2M $14.3M $25.4M $1.8M $5.4M
Accounts Receivable $263.0K
Inventory $825.0K $502.0K $888.0K $737.0K $597.0K $487.0K $639.0K $676.0K
Total Current Assets $5.7M $4.5M $5.5M $7.2M $15.0M $27.6M $4.1M $7.0M
Property, Plant & Equipment $476.0K $922.0K $4.8M $5.7M $4.0M $471.0K $190.0K $124.0K
Goodwill $302.0K
Intangible Assets (Excl. Goodwill) $142.0K $16.0K $21.0K $26.0K $31.0K $36.0K $41.0K $46.0K
Total Assets $9.5M $9.4M $15.4M $15.8M $21.8M $30.4M $9.1M $11.5M
Liabilities
Accounts Payable $382.0K $299.0K $636.0K $434.0K $241.0K $194.0K $191.0K $301.0K
Total Current Liabilities $3.7M $2.0M $2.9M $8.1M $2.7M $2.9M $2.1M $2.4M
Long-Term Debt $368.0K $287.0K $12.0K
Total Liabilities $6.6M $5.5M $6.6M $10.1M $4.6M $4.6M $3.9M $3.1M
Stockholders' Equity
Retained Earnings $-292.1M $-281.7M $-270.7M $-262.5M $-250.4M $-241.1M $-234.1M $-229.3M
Total Stockholders' Equity $2.9M $3.9M $8.8M $5.7M $17.2M $25.8M $5.2M $8.4M
← Newer Page 1 of 2 Older →